WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting

Corporate

Open PDF
  • A Leader in Venture Financings

    Wilson Sonsini is ranked as the No. 1 law firm in the U.S. and globally based on the number of company-side venture financing rounds raised for clients in 2025. (Source: LSEG Global Legal Private Equity and Venture Capital Review, Full Year 2025)

  • Ranked Among the Top Capital Markets Advisors to Companies and Underwriters

    We are consistently ranked by Bloomberg, Thomson Reuters, and CapitalIQ as a leading advisor to companies and underwriters based on the number of completed IPOs and equity and equity-linked offerings. Over the past 20 years, the firm has represented some of the world’s most iconic companies in such transactions, including Google, LinkedIn, Twitter, and Lyft.

  • Advise on Hundreds of M&A Deals Annually

    In 2025, Wilson Sonsini advised on more than 150 announced and/or completed M&A deals with an aggregate disclosed value of $100 billion. 

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.

Wilson Sonsini is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, employee benefits, and other corporate transactional areas.

Our clients are companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, and software sectors.

Overview

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology, life sciences, and growth enterprises worldwide, as well as the venture firms, private equity firms, and investment banks that finance them. We represent companies at every stage of development, from entrepreneurial start-ups to multibillion-dollar global corporations. The firm's attorneys collaborate across a comprehensive range of practice areas and industry groups to help the management, boards of directors, shareholders, and in-house counsel of our clients address their most pressing challenges and pursue their most promising opportunities.

Wilson Sonsini is nationally recognized for providing high-quality services to address the legal solutions required by its enterprise and financial institution clients. Our services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, employee benefits, and other corporate transactional areas.

Our clients are companies and other entities that compete in rapidly developing and innovative industries, including the biotech, communications, digital media, energy, financial services, medical devices, and software sectors.

News Articles
Wilson Sonsini Partners Sachin Kohli and Demian Ahn Contribute to Diligent’s Q4 GC Risk Index Report
Mergers & Acquisitions partner Sachin Kohli and Data, Privacy, and Cybersecurity partner Demian Ahn recently contributed to the Q4 edition of the General Counsel (GC) Risk Index report published by Diligent Institute. This report explores how legal leaders assess the current risk environment, what risks are driving those assessments, how AI governance is structured, how boards are preparing to oversee AI, and whether organizations are ready to respond to cyber events and related disclosure obligations.
Alerts
Delaware Corporation Law Council Proposes Amendments on Stockholder Proposals
On November 9, 2026, the Delaware Corporation Law Council (the Council)—a body of practitioners in Delaware that vets and proposes amendments to the Delaware General Corporation Law—announced potential statutory amendments addressing stockholders’ ability to make non-binding proposals at public company annual meetings. The proposed amendments follow the recent proposal by the U.S. Securities and Exchange Commission (SEC), described here,1 to rescind Rule 14a-8 of the Securities Exchange Act of 1934, which has largely regulated non-binding stockholder proposals for the last 80 years. The SEC’s proposal is pending and as was announced in August 2026, the SEC staff has discontinued its practice of responding to requests from companies for no-action relief to exclude a proposal under Rule 14a-8. The proposed Delaware amendments (the Amendments) are written to become effective if and when the SEC rescinds Rule 14a-8 and would provide the new replacement regime for Delaware corporations. The Amendments would clarify the landscape for Delaware corporations because existing Delaware law does not expressly address the subject.
Client Highlights
Wilson Sonsini Advises PacBio on $100 Million At-the-Market Stock Offering
On November 10, 2026, Pacific Biosciences of California, Inc. (PacBio), developer of the world’s most advanced sequencing technologies, entered into a sales agreement with Allen & Company LLC to offer up to $100 million of its common stock through an at-the-market program. Under the terms of the agreement, PacBio may offer and sell shares of its common stock having an aggregate offering price of up to $100 million from time to time through or to Allen & Company LLC, acting as PacBio’s sales agent or principal. Wilson Sonsini Goodrich & Rosati advised PacBio on the transaction.

PacBio intends to use the proceeds from this offering, together with existing cash, cash equivalents, and investments, for research and development and working capital and general corporate purposes.

The Wilson Sonsini team that advised PacBio on the transaction included Andrew Hoffman, Zachary Myers, Annie Giomi, James Keegan, and Mounika Yepuri.

For more information, please see PacBio’s prospectus supplement.
Client Highlights
Firm Represents Veteran Ventures Capital as Lead Investor in $6.95 Million Aformic Financing
On November 4, 2026, Veteran Ventures Capital (VVC) announced that it led a $6.95 million investment in Aformic, a robotics company that designs and deploys autonomous mobile robots and fleet-management software. Wilson Sonsini Goodrich & Rosati advised VVC on the transaction.
Client Highlights
Wilson Sonsini Advises Ancep on $8.5 Million Funding Round
On November 10, 2026, Ancep, a London-based start-up building artificial intelligence (AI) agents for commercial insurance brokers, emerged from stealth and announced it raised $8.5 million in a funding round led by Creandum. The round also included participation from Kleiner Perkins and Vicus Ventures, alongside angel investors including Christa Davies, former chief financial officer of Aon, and operators from OpenAI, Anthropic, and Google DeepMind. Ancep will use the new funds to support growth and hiring. Wilson Sonsini Goodrich & Rosati advised Ancep on the transaction.
Client Highlights
Wilson Sonsini Advises Graphon Labs on $35 Million Series A
On November 10, 2026, Graphon Labs, an applied artificial intelligence (AI) lab building Persistent Intelligence to power the next generation of AI agents and accelerate progress toward artificial general intelligence, announced a $35 million Series A led by RRE Ventures, with participation from HP, Energy Impact Partners, Hitachi Ventures, and Gaia VC. Wilson Sonsini Goodrich & Rosati advised Graphon Labs on the transaction.
View All
Insights
News Articles
Wilson Sonsini Partners Sachin Kohli and Demian Ahn Contribute to Diligent’s Q4 GC Risk Index Report
Mergers & Acquisitions partner Sachin Kohli and Data, Privacy, and Cybersecurity partner Demian Ahn recently contributed to the Q4 edition of the General Counsel (GC) Risk Index report published by Diligent Institute. This report explores how legal leaders assess the current risk environment, what risks are driving those assessments, how AI governance is structured, how boards are preparing to oversee AI, and whether organizations are ready to respond to cyber events and related disclosure obligations.
Alerts
Delaware Corporation Law Council Proposes Amendments on Stockholder Proposals
On November 9, 2026, the Delaware Corporation Law Council (the Council)—a body of practitioners in Delaware that vets and proposes amendments to the Delaware General Corporation Law—announced potential statutory amendments addressing stockholders’ ability to make non-binding proposals at public company annual meetings. The proposed amendments follow the recent proposal by the U.S. Securities and Exchange Commission (SEC), described here,1 to rescind Rule 14a-8 of the Securities Exchange Act of 1934, which has largely regulated non-binding stockholder proposals for the last 80 years. The SEC’s proposal is pending and as was announced in August 2026, the SEC staff has discontinued its practice of responding to requests from companies for no-action relief to exclude a proposal under Rule 14a-8. The proposed Delaware amendments (the Amendments) are written to become effective if and when the SEC rescinds Rule 14a-8 and would provide the new replacement regime for Delaware corporations. The Amendments would clarify the landscape for Delaware corporations because existing Delaware law does not expressly address the subject.
Client Highlights
Wilson Sonsini Advises PacBio on $100 Million At-the-Market Stock Offering
On November 10, 2026, Pacific Biosciences of California, Inc. (PacBio), developer of the world’s most advanced sequencing technologies, entered into a sales agreement with Allen & Company LLC to offer up to $100 million of its common stock through an at-the-market program. Under the terms of the agreement, PacBio may offer and sell shares of its common stock having an aggregate offering price of up to $100 million from time to time through or to Allen & Company LLC, acting as PacBio’s sales agent or principal. Wilson Sonsini Goodrich & Rosati advised PacBio on the transaction.

PacBio intends to use the proceeds from this offering, together with existing cash, cash equivalents, and investments, for research and development and working capital and general corporate purposes.

The Wilson Sonsini team that advised PacBio on the transaction included Andrew Hoffman, Zachary Myers, Annie Giomi, James Keegan, and Mounika Yepuri.

For more information, please see PacBio’s prospectus supplement.
Client Highlights
Firm Represents Veteran Ventures Capital as Lead Investor in $6.95 Million Aformic Financing
On November 4, 2026, Veteran Ventures Capital (VVC) announced that it led a $6.95 million investment in Aformic, a robotics company that designs and deploys autonomous mobile robots and fleet-management software. Wilson Sonsini Goodrich & Rosati advised VVC on the transaction.
Client Highlights
Wilson Sonsini Advises Ancep on $8.5 Million Funding Round
On November 10, 2026, Ancep, a London-based start-up building artificial intelligence (AI) agents for commercial insurance brokers, emerged from stealth and announced it raised $8.5 million in a funding round led by Creandum. The round also included participation from Kleiner Perkins and Vicus Ventures, alongside angel investors including Christa Davies, former chief financial officer of Aon, and operators from OpenAI, Anthropic, and Google DeepMind. Ancep will use the new funds to support growth and hiring. Wilson Sonsini Goodrich & Rosati advised Ancep on the transaction.
Client Highlights
Wilson Sonsini Advises Graphon Labs on $35 Million Series A
On November 10, 2026, Graphon Labs, an applied artificial intelligence (AI) lab building Persistent Intelligence to power the next generation of AI agents and accelerate progress toward artificial general intelligence, announced a $35 million Series A led by RRE Ventures, with participation from HP, Energy Impact Partners, Hitachi Ventures, and Gaia VC. Wilson Sonsini Goodrich & Rosati advised Graphon Labs on the transaction.
View All
Affiliated Programs
Behind the Raise: The Financial Journey for Life Science Founders
Wilson Sonsini is pleased to sponsor the University of San Diego Knauss School of Business Center for Applied Finance symposium, which will focus on the key considerations and strategies for raising capital in the early stages of building a life sciences company.
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Affiliated Programs
Wilson Sonsini and HBA San Francisco Bay Area Chapter Year-End Educational Networking Event
Wilson Sonsini Goodrich & Rosati is proud to sponsor the Healthcare Businesswomen’s Association (HBA).
Affiliated Programs
UT Venture Fellows Fall Mock Negotiation
Please join Wilson Sonsini Goodrich & Rosati and the Venture Fellows from the UT McCombs School of Business at our company formation mock negotiation.
Affiliated Programs
2026 US-Japan Healthcare Innovation Conference
Wilson Sonsini is pleased to sponsor the 2026 US-Japan Healthcare Innovation Conference.
Affiliated Programs
HLTH 2026
Wilson Sonsini will host multiple events during HLTH 2026 in Las Vegas. Please see below for details.

Digital Health Reception Sunday, November 15
7:00 - 10:00 p.m.
View All
Events
Affiliated Programs
Behind the Raise: The Financial Journey for Life Science Founders
Wilson Sonsini is pleased to sponsor the University of San Diego Knauss School of Business Center for Applied Finance symposium, which will focus on the key considerations and strategies for raising capital in the early stages of building a life sciences company.
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Affiliated Programs
Wilson Sonsini and HBA San Francisco Bay Area Chapter Year-End Educational Networking Event
Wilson Sonsini Goodrich & Rosati is proud to sponsor the Healthcare Businesswomen’s Association (HBA).
Affiliated Programs
UT Venture Fellows Fall Mock Negotiation
Please join Wilson Sonsini Goodrich & Rosati and the Venture Fellows from the UT McCombs School of Business at our company formation mock negotiation.
Affiliated Programs
2026 US-Japan Healthcare Innovation Conference
Wilson Sonsini is pleased to sponsor the 2026 US-Japan Healthcare Innovation Conference.
Affiliated Programs
HLTH 2026
Wilson Sonsini will host multiple events during HLTH 2026 in Las Vegas. Please see below for details.

Digital Health Reception Sunday, November 15
7:00 - 10:00 p.m.
View All
Lester Ang
Partner
Palo Alto
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
  • Corporate
View Profile
Brian Appel
Partner
Palo Alto
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
  • Corporate
View Profile
Mark Bass
Partner
Washington, D.C.
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings. 
  • Corporate
View Profile
Mark B. Baudler
Partner
San Francisco
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
  • Corporate
View Profile
Steven V. Bernard
Partner
Palo Alto

Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.

  • Corporate
View Profile
Ashmi Bhagani
Partner
London
Ashmi Bhagani is a partner in the London office of Wilson Sonsini Goodrich & Rosati, where she has a diverse transatlantic corporate and securities practice focused on the technology and life sciences sectors.
  • Corporate
View Profile
Richard C. Blake
Partner
Palo Alto
Richard has a comprehensive corporate law background, with extensive experience in public offerings.
  • Corporate
View Profile
Lance E. Brady
Partner
Palo Alto
Lance Brady is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto office, where his practice focuses on representing public and private life sciences and technology companies through all stages of their growth. Lance advises his clients on a broad variety of transactions and corporate matters, including initial formation and organization, equity and debt financings, mergers and acquisitions, public offerings, spin-outs, corporate governance, SEC compliance and public company reporting requirements. He also has extensive experience representing venture capital and other institutional investors in financing transactions.
  • Corporate
View Profile
Jason Breen
Partner
Los Angeles
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
  • Mergers & Acquisitions
View Profile
Tamara Brightwell
Partner
Washington, D.C.
Tamara Brightwell is a corporate partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she counsels public company clients on a wide range of regulatory matters and provides securities law advice on complex capital markets transactions.
  • Corporate
View Profile
View All
People
Lester Ang
Partner
Palo Alto
Lester Ang is a corporate and securities partner in the Palo Alto office of Wilson Sonsini, where he works with private and public technology and life sciences companies through all stages of their growth, as well as with venture capital firms and private equity firms.
  • Corporate
View Profile
Brian Appel
Partner
Palo Alto
Brian Appel is a partner in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he practices corporate and securities law. He advises companies on general corporate matters, including formation and operation, corporate governance, debt and equity financings, mergers and acquisitions, and securities-related matters. He has assisted early-stage companies in numerous capital-raising transactions, including venture capital financings.
  • Corporate
View Profile
Mark Bass
Partner
Washington, D.C.
Mark Bass is a partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where he works with public and private technology companies at all stages of growth. He also represents venture capital funds, private equity firms, and investment banks in financings and public offerings. 
  • Corporate
View Profile
Mark B. Baudler
Partner
San Francisco
Mark is a corporate law veteran, having advised start-ups and mature public companies for more than 25 years.
  • Corporate
View Profile
Steven V. Bernard
Partner
Palo Alto

Steve has represented non-U.S. and domestic companies in U.S. IPOs, global securities offerings, cross-border M&A, and SEC compliance for more than 25 years.

  • Corporate
View Profile
Ashmi Bhagani
Partner
London
Ashmi Bhagani is a partner in the London office of Wilson Sonsini Goodrich & Rosati, where she has a diverse transatlantic corporate and securities practice focused on the technology and life sciences sectors.
  • Corporate
View Profile
Richard C. Blake
Partner
Palo Alto
Richard has a comprehensive corporate law background, with extensive experience in public offerings.
  • Corporate
View Profile
Lance E. Brady
Partner
Palo Alto
Lance Brady is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto office, where his practice focuses on representing public and private life sciences and technology companies through all stages of their growth. Lance advises his clients on a broad variety of transactions and corporate matters, including initial formation and organization, equity and debt financings, mergers and acquisitions, public offerings, spin-outs, corporate governance, SEC compliance and public company reporting requirements. He also has extensive experience representing venture capital and other institutional investors in financing transactions.
  • Corporate
View Profile
Jason Breen
Partner
Los Angeles
Jason Breen is a partner in the Los Angeles office of Wilson Sonsini Goodrich & Rosati, where he represents public and private companies at all stages of growth in M&A transactions, primarily working with clients in the life sciences and technology industries. Jason also represents venture capital, growth equity, and private equity funds and focuses on other strategic transactions, including divestitures, joint ventures, and financings.
  • Mergers & Acquisitions
View Profile
Tamara Brightwell
Partner
Washington, D.C.
Tamara Brightwell is a corporate partner in the Washington, D.C., office of Wilson Sonsini Goodrich & Rosati, where she counsels public company clients on a wide range of regulatory matters and provides securities law advice on complex capital markets transactions.
  • Corporate
View Profile
View All
Related Practices
  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Life Sciences Business Advisory Practice
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Special Purpose Acquisition Companies (SPACs)
  • Tax
  • U.S. Expansion
Recent Insights
News Articles
Wilson Sonsini Partners Sachin Kohli and Demian Ahn Contribute to Diligent’s Q4 GC Risk Index Report
Mergers & Acquisitions partner Sachin Kohli and Data, Privacy, and Cybersecurity partner Demian Ahn recently contributed to the Q4 edition of the General Counsel (GC) Risk Index report published by Diligent Institute. This report explores how legal leaders assess the current risk environment, what risks are driving those assessments, how AI governance is structured, how boards are preparing to oversee AI, and whether organizations are ready to respond to cyber events and related disclosure obligations.
Learn More
Alerts
Delaware Corporation Law Council Proposes Amendments on Stockholder Proposals
On November 9, 2026, the Delaware Corporation Law Council (the Council)—a body of practitioners in Delaware that vets and proposes amendments to the Delaware General Corporation Law—announced potential statutory amendments addressing stockholders’ ability to make non-binding proposals at public company annual meetings. The proposed amendments follow the recent proposal by the U.S. Securities and Exchange Commission (SEC), described here,1 to rescind Rule 14a-8 of the Securities Exchange Act of 1934, which has largely regulated non-binding stockholder proposals for the last 80 years. The SEC’s proposal is pending and as was announced in August 2026, the SEC staff has discontinued its practice of responding to requests from companies for no-action relief to exclude a proposal under Rule 14a-8. The proposed Delaware amendments (the Amendments) are written to become effective if and when the SEC rescinds Rule 14a-8 and would provide the new replacement regime for Delaware corporations. The Amendments would clarify the landscape for Delaware corporations because existing Delaware law does not expressly address the subject.
Learn More
View All
Recent Events
Affiliated Programs
Behind the Raise: The Financial Journey for Life Science Founders
Wilson Sonsini is pleased to sponsor the University of San Diego Knauss School of Business Center for Applied Finance symposium, which will focus on the key considerations and strategies for raising capital in the early stages of building a life sciences company.
Learn More
Speaking Engagements
PLI's Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings 2026
Practising Law Institute (PLI) features specialized sessions on tax strategies for financially troubled businesses within its premier annual conference series on Tax Strategies for Corporate Acquisitions, Dispositions, Spin-Offs, Joint Ventures, Financings, Reorganizations & Restructurings. These programs focus on navigating net operating losses (NOLs), debt restructurings, and corporate distress under complex federal tax rules.
Learn More
View All
Newsletters
2024 Mid-Year Technology and Life Sciences PIPE and RDO Report
Wilson Sonsini Goodrich & Rosati is pleased to present the 2024 Mid-Year Technology and Life Sciences PIPE and RDO Report, analyzing 124 private investments in public equity (PIPEs) and registered direct offerings (RDOs) by U.S.-based tech and life science companies between January 1 and June 30, 2024.
Read the Report
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Cookie Settings
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.